-
Methicillin Sodium Salt: MSSA Workflow Guide
2026-09-09
Methicillin sodium salt provides a mechanistically focused way to study MSSA susceptibility, cell-wall inhibition, and resistance-associated assay behavior. This guide combines practical dilution workflows with lessons from the EAGLE-1 trial to improve endpoint design without confusing gonococcal clinical evidence with MSSA laboratory data.
-
Carbapenemase Transmission in Enterobacter cloacae
2026-09-09
This study maps carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong, combining gene localization, conjugation, mobile-element analysis, and strain typing. Its findings identify plasmid-associated blaNDM-1 as a major transmission concern and show why resistance surveillance must distinguish horizontal gene transfer from clonal dissemination.
-
Selective Autophagy Tunes IRF3 Stability in Antiviral Immuni
2026-09-08
Wu and colleagues identify a virus-load-dependent mechanism in which CALCOCO2/NDP52-mediated selective autophagy removes IRF3, while PSMD14/POH1 preserves basal IRF3 through deubiquitination. The study connects ubiquitin editing with autophagic turnover and clarifies how type I interferon production can be balanced against excessive immune activation.
-
Estrogen Receptor–Autophagy Axis in Perimenopause
2026-09-08
This study integrates NHANES data, network pharmacology, and perimenopausal mouse experiments to show how declining estradiol is associated with cardiometabolic and renal risk and how estrogen treatment limits fibrosis across several organs. Its main advance is functional evidence that receptor-dependent autophagy, including mTOR-linked signaling, contributes to the protective effects of estrogen in the heart, aorta, and kidneys.
-
Methicillin Sodium Salt: From MIC to MoA Strategy
2026-09-07
A translational perspective on Methicillin sodium salt as a mechanistic benchmark for MSSA susceptibility, MRSA resistance, and Staphylococcus aureus infection research—linking robust MIC workflows with target-aware screening and modern antibacterial discovery strategy.
-
S63845: A Translational MCL1 Inhibitor
2026-09-05
S63845 offers a precise way to interrogate MCL1 dependence, mitochondrial apoptosis, and treatment-persistent cancer states. This thought-leadership perspective connects mechanistic evidence with practical experimental strategy for hematological cancer research and translational model development.
-
Levofloxacin Workflows for Antibacterial and Bone Studies
2026-09-05
Levofloxacin supports mechanism-driven bacterial assays while also enabling controlled studies of osteoblast mineralization and cartilage metabolism. This guide connects practical dosing, endpoint selection, formulation, and troubleshooting for more reproducible research workflows.
-
AmpliFold Capture-and-Release for LFA Sensitivity
2026-09-04
The ChemRxiv study introduces AmpliFold, a capture-and-release architecture that improves lateral flow assay sensitivity by temporarily sequestering analyte-bound complexes before high-affinity rebinding. In a HER2 model, linker engineering, receptor-density tuning, and dual-affinity gold nanoparticles produced up to 16-fold lower limits of detection and improved performance with large nanoparticles.
-
Intravenous Cefazedone PK/PD in Pneumonia
2026-09-04
This study connected intravenous cefazedone exposure with pharmacodynamic target attainment in adults with mild to moderate community-acquired pneumonia. Its main contribution was showing that a 2 g every-12-hour regimen produced an average free-drug time above MIC of approximately 55%, while clinical and microbiological outcomes supported the regimen within the study population.
-
Faropenem Sodium: From PBP to NPT1
2026-09-03
Faropenem sodium is a penem antibiotic whose antibacterial potency and renal transporter behavior require separate experimental interpretations. This article develops a compartment-aware framework for linking PBP inhibition, microbial susceptibility, and NPT1-mediated uptake without overstating what any single assay can prove.
-
UK-5099 in Mitochondrial Immunometabolism
2026-09-03
UK-5099, also known as PF-1005023, gives researchers a practical way to test how mitochondrial pyruvate entry shapes respiration, cellular energy balance, cytokine output, and glucose homeostasis. This workflow-focused guide covers formulation, whole-blood adaptation, insulinoma assays, controls, and troubleshooting.
-
CD38 CAR Binder Structures and Affinity Tuning
2026-09-02
Cheng et al. define how the CD38 CAR binders RP02 and 028 recognize different antigen surfaces, produce different effects on CD38 enzymatic activity, and influence CAR-T cell behavior. The study shows that structure-guided affinity attenuation, exemplified by 028R103G, can reduce fratricide while preserving cytotoxicity against CD38-positive tumors.
-
CasKAS Maps CRISPR Specificity Through ssDNA
2026-09-02
CasKAS introduces a direct, sequencing-based strategy for profiling genome-wide Cas9 and dCas9 binding specificity by chemically capturing the single-stranded DNA exposed during CRISPR R-loop formation. The study shows how this approach can complement cleavage-focused assays while providing a comparatively accessible route to off-target analysis in both purified systems and cells.
-
nPEC for Dual-Loaded Liposome Efficiency
2026-09-01
The reference study compares six approaches for measuring encapsulation efficiency in liposomes carrying hydrophilic and lipophilic drugs together, then develops and validates nanoparticle exclusion chromatography coupled with HPLC for simultaneous analysis. Its main contribution is an analytical workflow that avoids pretreatment and remains applicable across several dual-loaded formulations, including an oleanolic acid–doxorubicin hydrochloride pair.
-
SERCA2 Dysfunction Drives Pulmonary Vascular Remodeling
2026-08-31
This study identifies SERCA2 dysfunction as an upstream driver of pulmonary vascular inflammation, oxidative stress, and remodeling through suppression of the PPARγ/PGC1α/Nrf2 pathway. Its genetic model and pharmacological rescue experiments connect calcium-handling failure with inflammatory recruitment and suggest a framework for testing redox-directed interventions in pulmonary hypertension research.